SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: KHS who wrote (13004)8/11/1998 12:23:00 AM
From: Mkilloran  Read Replies (1) of 23519
 
khs...maybe Vivus is being quit to setup the 3rd qtr earnings for a good suprise to exceed analyst estimates.....

They have reduced cost in the new factory, scaled down R&D and eliminated sales staff expenses...have capacity for 5 mill units of Muse this qtr and may just not want to broadcast each country as they receive approval...save it all for a good conf call in the 3rd qtr....

It could be their way to re- gain support on Wall Street...show them the earnings....

Waiting for China to start selling...the deal with Vivus and Janssen allows for royalties on sales going back to Vivus...they cut a deal with Janssen when they were the only game in town...it will payoff as China sales show up on the bottom line...

Japan is still a wild card that Vivus has not played...to be put out to bid to determine who will get the sales distribution in Japan...Janssen or Astra or ?????
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext